Keynote Speakers

Maria A. Oquendo

Maria A. Oquendo

Philadelphia, USA

Ruth Meltzer Professor and Chairman of Psychiatry
Perelman School of Medicine, University of Pennsylvania
American Psychiatric Association, Immediate Past President
International Academy of Suicide Research, Immediate Past President

Maria Melchior

Maria Melchior

Paris, France

Maria Melchior holds a PhD in epidemiology and public health (Harvard University). She‘s currently Research Director at the French National Institute of Health and Medical Research (INSERM). Her research focuses on social inequalities in mental health, with a particular emphasis on developmental trajectories from childhood to adulthood and the intergenerational transmission of psychiatric disorders. Most projects have relied on data collected in longitudinal cohort studies of children set up in France (EDEN, ELFE, TEMPO) or other countries (Dunedin study set in New Zealand, ELDEQ in Canada). Currently, she’s also coordinating the DEPICT repeated cross-sectional study which aims to evaluate changes in the perception of tobacco smoking and social disparities in this area, particularly among young people. Maria Melchior received the Research Prize of the European Psychiatric Association (2012) and the Early Career Award of the International Society of Behavioral Medicine (2004). She is the author or co-author of over 100 publications in international peer-reviewed journals.

David R. Rubinow

David R. Rubinow

Chapel Hill, USA

Dr. David Rubinow is the Assad Meymandi Professor and Chair of the Department of Psychiatry at the University of North Carolina - Chapel Hill, School of Medicine. Prior to joining UNC, he was the Clinical Director of the National Institute of Mental Health (NIMH) and Chief of the Behavioral Endocrinology Branch. His research interests focus on neurobehavioral effects of gonadal steroids and how genetic variation contributes to differential behavioral response to changes in steroid signaling. Research methods used include administration of hormone super agonists and receptor blockers to manipulate the menstrual cycle and identify the central effects of gonadal steroids in isolation. These studies have demonstrated that, unlike mood disorders accompanying endocrinopathies, reproductive endocrine-related mood disorders represent abnormal responses to normal hormonal signals. Current NIH funded studies include investigations of continuous oral contraceptive administration in menstrual cycle-related mood disorders, estradiol effects on cardiovascular risk and mood dysregulation during the perimenopause, and biomarkers of postpartum depression. Additionally, the UNC Women’s Mood Disorders Program, which he directs, has the first and only NIH training fellowship in Women’s Mood Disorders. On the basis of his research, he was inducted into the Institute of Medicine of the National Academies in 2012. Dr. Rubinow is also the Director of the UNC Center for Innovation and Health Care System Transformation, which promotes the development of patient-centered innovations designed to address the current challenges facing our nation’s health care delivery system.

Keynote Speakers of 8th World Congress IAWMH 2019